Presentation TCT 2023

TCT 260: Tricuspid Regurgitation and Heart Failure: the Fate of Treated vs Untreated in the Percutaneous Era. What is clear now?

Presenter: Edoardo Aancanaro

October 25, 2023

REGISTER for free or LOG IN to view this content

TCT 260: Tricuspid Regurgitation and Heart Failure: the Fate of Treated vs Untreated in the Percutaneous Era. What is clear now?

Structural Heart

TCT 2023

Tricuspid Valve

Up Next

Presentation TCT 2023

TCT 318: First in Human Tricuspid Valve Replacement Compassionate Use Experience with a Novel Transcatheter Heart Valve Replacement System

Presenter: Jörg Hausleiter

October 25, 2023

More slides +

Presentation TCT 2023

TCT 373: Evaluation of the New Version of the MonarQ Transcatheter Tricuspid Bioprosthesis in a Large Animal Model

Presenter: Arshad Quadri

October 25, 2023

Presentation TCT 2023

TCT 140: Combined Coexistence of Multiple Vulnerable Plaque Features is Associated with Incremental Rates of Adverse Events in Patients with Diabetes Mellitus. New Insights From the COMBINE OCT-FFR trial

Presenter: David del Val

October 25, 2023

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.